The team of researchers found that a specific type of glycan, a complex sugar molecule, could be a new target for early diagnostic tests, treatments, and possibly prevention of Alzheimer’s disease.

The scientists developed an insulin molecule with an “on-and-off switch” that automatically responds to sugar levels in the ...